Hannes A Rüdiger1,2, Krzystof Piasecki2, Fabio Becce3, Stéphane Cherix2. 1. Department of Orthopaedics, Schulthess Clinic, Zürich - Switzerland. 2. Department of Orthopaedics and Traumatology, Lausanne University Hospital (CHUV), Lausanne - Switzerland. 3. Department of Diagnostic and Interventional Radiology, Lausanne University Hospital (CHUV), Lausanne - Switzerland.
Abstract
BACKGROUND: Surgical access to benign neoplastic lesions of the femoral head are associated with significant morbidity, including contamination of intra-osseous access tracks, articular cartilage lesions, avascular bone necrosis or tumour recurrence due to incomplete curettage. CASE PRESENTATION: We present a case of a 20-year-old female with a giant cell tumour in the femoral head, which was treated with curettage through a trans-foveal approach and bone grafting. This technique includes a surgical dislocation of the hip with trochanteric osteotomy. RESULTS: At the latest follow-up at 2 years, there was no evidence of local recurrence or avascular necrosis on MRI, and the patient was pain free and back to sports.
BACKGROUND: Surgical access to benign neoplastic lesions of the femoral head are associated with significant morbidity, including contamination of intra-osseous access tracks, articular cartilage lesions, avascular bone necrosis or tumour recurrence due to incomplete curettage. CASE PRESENTATION: We present a case of a 20-year-old female with a giant cell tumour in the femoral head, which was treated with curettage through a trans-foveal approach and bone grafting. This technique includes a surgical dislocation of the hip with trochanteric osteotomy. RESULTS: At the latest follow-up at 2 years, there was no evidence of local recurrence or avascular necrosis on MRI, and the patient was pain free and back to sports.